Skip to main content

Table 1 The baseline characteristics of the patients

From: Biweekly oxaliplatin plus S1 for Chinese elderly patients with advanced gastric or gastroesophageal junction cancer as the first-line therapy: a single-arm, phase 2 study

 

No

%

Gender

 Male

34

81.0

 Female

8

19.0

Age (years)

 60 ~  < 65

9

21.4

 65 ~  < 70

18

42.9

 70 ~  < 75

11

26.2

  ≥ 75

4

9.5

ECOG

 0

25

59.5

 1

17

40.5

BMI

 Low (< 18.5 kg/m2)

5

11.9

 Normal (18.5 ~  < 24 kg/m2)

22

52.4

 Overweight (24 ~  < 27 kg/m2)

10

23.8

 Obesity (27 ~  < 30 kg/m2)

3

7.1

 Severe obesity (≥ 30 kg/m2)

1

2.4

 Unknown

1

2.4

Disease status

 Recurrent

4

9.5

 Newly diagnosed

38

90.5

HER2 status

 HER2 positive

7

16.7

 HER2 negative

30

71.4

 Unknown

5

11.9

Metastatic site

 Retroperitoneal lymph nodes

25

59.3

 Supraclavicular lymph nodes

16

38.1

 Mediastinal lymph nodes

12

28.6

 Liver

10

23.8

 Peritoneal

10

23.8

 Lung

10

23.8

 Adrenal gland

2

4.8

 Bone

1

2.4

 Ovary

1

2.4

Existing physical illness

 Hypertension

9

21.4

 Diabetes

5

11.9

 Coronary heart disease

5

11.9

 Cerebral infarction

3

7.1

 Carotid artery stenosis

2

4.8

 Arrhythmia

2

4.8

 Liver cirrhosis

1

2.4